List of bibliographic references
Number of relevant bibliographic references: 19.
| Ident. | Authors (with country if any) | Title |
|---|
| 000198 (2011) |
Kevin B. Kim ; Jason Chesney ; Douglas Robinson ; Humphrey Gardner ; Michael M. Shi ; John M. Kirkwood | Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258), an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors, in Patients with Advanced Melanoma |
| 000553 (2012) |
Ahmad A. Tarhini ; John Cherian ; Stergios J. Moschos ; Hussein A. Tawbi ; YONGLI SHUAI ; William E. Gooding ; Cindy Sander ; John M. Kirkwood | Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma |
| 000685 (2012) |
Julien Fourcade ; ZHAOJUN SUN ; Ornella Pagliano ; Philippe Guillaume ; Immanuel F. Luescher ; Cindy Sander ; John M. Kirkwood ; Daniel Olive ; Vijay Kuchroo ; Hassane M. Zarour | CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1 |
| 000A05 (2012) |
Kim A. Margolin ; James Moon ; Lawrence E. Flaherty ; Christopher D. Lao ; Wallace L. Iii Akerley ; Megan Othus ; Jeffrey A. Sosman ; John M. Kirkwood ; Vernon K. Sondak | Randomized Phase II Trial of Sorafenib with Temsirolimus or Tipifarnib in Untreated Metastatic Melanoma (S0438) |
| 000A94 (2012) |
Antoni Ribas ; Peter Hersey ; Mark R. Middleton ; Helen Gogas ; Keith T. Flaherty ; Vernon K. Sondak ; John M. Kirkwood | New Challenges in Endpoints for Drug Development in Advanced Melanoma |
| 000A95 (2012) |
John M. Kirkwood ; Lars Bastholt ; Caroline Robert ; Jeff Sosman ; James Larkin ; Peter Hersey ; Mark Middleton ; Mireille Cantarini ; Victoria Zazulina ; Karin Kemsley ; Reinhard Dummer | Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma |
| 000B68 (2012) |
Ahmad A. Tarhini ; SIYANG LENG ; Stergios J. Moschos ; YAN YIN ; Cindy Sander ; YAN LIN ; William E. Gooding ; John M. Kirkwood | Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma |
| 000B91 (2012) |
Clara Curiel-Lewandrowski ; Caroline C. Kim ; Susan M. Swetter ; Suephy C. Chen ; Allan C. Halpern ; John M. Kirkwood ; Sancy A. Leachman ; Ashfaq A. Marghoob ; Michael E. Ming ; James M. Grichnik | Survival Is Not the Only Valuable End Point in Melanoma Screening |
| 001223 (2012) |
Carsten Schaefer ; Lisa H. Butterfield ; Sandra Lee ; Grace G. Kim ; Carmen Visus ; Andreas Albers ; John M. Kirkwood ; Theresa L. Whiteside | Function but not phenotype of melanoma peptide-specific CD8+ T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696) |
| 001B57 (2012) |
Ahmad A. Tarhini ; Lisa H. Butterfield ; Yongli Shuai ; William E. Gooding ; Pawel Kalinski ; John M. Kirkwood | Differing Patterns of Circulating Regulatory T Cells and Myeloid-derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Agonist and GM-CSF With Peptide Vaccination |
| 002244 (2013) |
Antoni Ribas ; Richard Kefford ; Margaret A. Marshall ; Cornelis J. A. Punt ; John B. Haanen ; Maribel Marmol ; Claus Garbe ; Helen Gogas ; Jacob Schachter ; Gerald Linette ; Paul Lorigan ; Kari L. Kendra ; Michele Maio ; Uwe Trefzer ; Michael Smylie ; Grant A. Mcarthur ; Brigitte Dreno ; Paul D. Nathan ; Jacek Mackiewicz ; John M. Kirkwood ; Jesus Gomez-Navarro ; BO HUANG ; Dmitri Pavlov ; Axel Hauschild | Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma |
| 002335 (2013) |
Keith T. Flaherty ; Sandra J. Lee ; FENGMIN ZHAO ; Lynn M. Schuchter ; Lawrence Flaherty ; Richard Kefford ; Michael B. Atkins ; Philip Leming ; John M. Kirkwood | Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma |
| 002396 (2013) |
John M. Kirkwood ; Ahmad Tarhini ; Joseph A. Sparano ; Prapti Patel ; Joan H. Schiller ; Maxwell T. Vergo ; Al B. Iii Benson ; Hussein Tawbi | Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors |
| 002C87 (2013) |
Craig L. Jr Slingluff ; Sandra Lee ; FENGMIN ZHAO ; Kimberly A. Chianese-Bullock ; Walter C. Olson ; Lisa H. Butterfield ; Theresa L. Whiteside ; Philip D. Leming ; John M. Kirkwood | A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602) |
| 003207 (2013) |
Bruce J. Averbook ; Sandra J. Lee ; Keith A. Delman ; Kenneth W. Gow ; Jonathan S. Zager ; Vernon K. Sondak ; Jane L. Messina ; Michael S. Sabel ; Mark R. Pittelkow ; Phillip M. Ecker ; Svetomir N. Markovic ; Susan M. Swetter ; Sancy A. Leachman ; Alessandro Testori ; Clara Curiel-Lewandrowski ; Ronald S. Go ; Drazen M. Jukic ; John M. Kirkwood | Pediatric Melanoma: Analysis of an International Registry |
| 003440 (2013) |
Ronald S. Go ; Sandra J. Lee ; DONGHOON SHIN ; Steven M. Callister ; Dean A. Jobe ; Robert M. Conry ; Ahmad A. Tarhini ; John M. Kirkwood | ECOG Phase II Trial of Graded-Dose Peginterferon α-2b in Patients with Metastatic Melanoma Overexpressing Basic Fibroblast Growth Factor (E2602) |
| 003942 (2014) |
Julien Fourcade ; ZHAOJUN SUN ; Ornella Pagliano ; Joe-Marc Chauvin ; Cindy Sander ; Bratislav Janjic ; Ahmad A. Tarhini ; Hussein A. Tawbi ; John M. Kirkwood ; Stergios Moschos ; HONG WANG ; Philippe Guillaume ; Immanuel F. Luescher ; Arthur Krieg ; Ana C. Anderson ; Vijay K. Kuchroo ; Hassane M. Zarour | PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines |
| 003C97 (2014) |
Melissa A. Wilson ; FENGMIN ZHAO ; Richard Letrero ; Kurt D'Andrea ; David L. Rimm ; John M. Kirkwood ; Harriet M. Kluger ; Sandra J. Lee ; Lynn M. Schuchter ; Keith T. Flaherty ; Katherine L. Nathanson | Correlation of Somatic Mutations and Clinical Outcome in Melanoma Patients Treated with Carboplatin, Paclitaxel, and Sorafenib |
| 004211 (2014) |
F. Stephen Hodi ; Sandra Lee ; David F. Mcdermott ; Uma N. Rao ; Lisa H. Butterfield ; Ahmad A. Tarhini ; Philip Leming ; Igor Puzanov ; DONGHOON SHIN ; John M. Kirkwood | Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma: A Randomized Clinical Trial |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "KIRKWOOD (John M.)"
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i \
-Sk "KIRKWOOD (John M.)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= PascalFrancis
|étape= Merge
|type= indexItem
|index= FA11s1.i
|clé= KIRKWOOD (John M.)
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021 |  |
